Shahrooz Ghaderi

547 citations
15 papers · 443 indexed · h-index 10
Topics
Cancer, Hypoxia, and Metabolism (2 papers)Erythrocyte Function and Pathophysiology (2 papers)MicroRNA in disease regulation (2 papers)

In The Last Decade

Shahrooz Ghaderi

15 papers receiving 440 citations

Peers

Shahrooz Ghaderi
Comparison fields: 5 of 88
  • Molecular Biology 225
  • Materials Chemistry 134
  • Cancer Research 75
  • Biomedical Engineering 74
  • Electrical and Electronic Engineering 49
Replace Zhengxia Liu with:
Zhengxia Liu China
Jung Woo Byun South Korea
Xiaojie Huang China
Zahra Azizi Iran
Rosa Mistica C. Ignacio South Korea
Saeideh Jafarinejad‐Farsangi Iran
Jianwei Duan China
Shahrooz Ghaderi relative to Zhengxia Liu China Zhengxia Liu's profile →
Citations per field
00.5×4.9×
Zhengxia Liu · 1×
Citations per year

Countries citing papers authored by Shahrooz Ghaderi

Since Specialization
Citations

This map shows the geographic impact of Shahrooz Ghaderi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shahrooz Ghaderi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shahrooz Ghaderi more than expected).

Fields of papers citing papers by Shahrooz Ghaderi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shahrooz Ghaderi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shahrooz Ghaderi. The network helps show where Shahrooz Ghaderi may publish in the future.

Co-authorship network of co-authors of Shahrooz Ghaderi

This figure shows the co-authorship network connecting the top 25 collaborators of Shahrooz Ghaderi. A scholar is included among the top collaborators of Shahrooz Ghaderi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shahrooz Ghaderi. Shahrooz Ghaderi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
#WorkIndexed citations
1 9
2 3
3 21
4 1
5 30
6 3
7 9
8 65
9 33
10 21
11 37
12 119
13 57
14 12
15 23

About Shahrooz Ghaderi

Shahrooz Ghaderi is a scholar working on Cancer Research, Periodontics and Physiology, having authored 15 papers that have together received 443 indexed citations. Recurring topics across this work include Cancer, Hypoxia, and Metabolism (2 papers), Erythrocyte Function and Pathophysiology (2 papers) and MicroRNA in disease regulation (2 papers). The work is most often cited by research in Cancer Research (75 citations), Molecular Biology (225 citations) and Materials Chemistry (134 citations). Shahrooz Ghaderi has collaborated with scholars based in Iran, Germany and United Kingdom. Frequent co-authors include Abolfazl Akbarzadeh, Reza Rahbarghazi‬, Bakiye Göker Bağca, Nafi Dilaver, Çığır Biray Avcı, Aysa Rezabakhsh, Alireza Nourazarian, Mehdi Hassanpour, Soodabeh Davaran and Hesam Saghaei Bagheri. Their work appears in journals such as Nature Communications, The Journal of Physiology and Pharmacology & Therapeutics.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026